Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Naoko Nakai"'
Autor:
Tsuyoshi Mayumi, Shinya Hosaka, Yutaka Yasuda, Takuho Ishii, Makoto Niwa, Tatsuya Yamakawa, Ayumi Ueda, Naoko Nakai
Publikováno v:
Bioanalysis. 12:7-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89d9e1236ea363a3b783ce370e0a4dac
https://doi.org/10.4155/bio-2019-0217
https://doi.org/10.4155/bio-2019-0217
Autor:
Tsuyoshi Mayumi, Takuho Ishii, Shinya Hosaka, Keita Ono, Yutaka Yasuda, Makoto Niwa, Naoko Nakai, Saori Kuriyama, Tatsuya Yamakawa
Publikováno v:
Bioanalysis. 10:1553-1556
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c85d52df13f9df18078824c40c0e296a
https://doi.org/10.4155/bio-2018-0217
https://doi.org/10.4155/bio-2018-0217
Autor:
Naohiro Nishimura, Akiko Toda, Naoko Nakai, Takuho Ishii, Yutaka Yasuda, Makoto Niwa, Keita Ono, Tatsuya Yamakawa, Takahide Uchimura, Nozomu Koseki, Hiroko Ashizawa, Kuretake Soejima, Saori Kuriyama, Tsuyoshi Mayumi
Publikováno v:
Bioanalysis. 9(13)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5065feb6e0b4ad6f9184a10e39409403
https://pubmed.ncbi.nlm.nih.gov/28708436
https://pubmed.ncbi.nlm.nih.gov/28708436
Autor:
Teruko Imai, Takashi Izumi, Daisuke Nakai, Makoto Takahashi, Naoko Nakai, Nobuhiro Kobayashi, Kumiko Koyama
Publikováno v:
Drug Metabolism and Disposition. 41:180-187
Laninamivir octanoate (LO) (Inavir; Daiichi Sankyo, Japan) is an ester prodrug of the neuraminidase inhibitor laninamivir. We previously reported that a prolonged high retention of laninamivir in mouse respiratory tissues was achieved by intranasal a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aa76a5742233385f4fb1d011cbd29b8
https://doi.org/10.1124/dmd.112.048280
https://doi.org/10.1124/dmd.112.048280
Autor:
Hideo Takakusa, Naoko Nakai, Osamu Okazaki, Kumiko Koyama, Nobuhiro Kobayashi, Takahiro Murai, Masayuki Takahashi, Naotoshi Yamamura, M Hoshi
Publikováno v:
Xenobiotica. 40:207-216
CS-8958, a prodrug of laninamivir (R-125489), is currently under development as an inhaled anti-influenza drug. In this study, the pharmacokinetics and disposition of CS-8958 were characterized in rats. After intratracheal administration of 14C-CS-89
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5050b376f6973b9ab69f5973747c6e96
https://doi.org/10.3109/00498250903447691
https://doi.org/10.3109/00498250903447691
Autor:
Osamu Okazaki, Makoto Takahashi, Kumiko Koyama, Naoko Nakai, Hideo Takakusa, Shin-ichi Miura, Masataka Oitate
Publikováno v:
Antimicrobial Agents and Chemotherapy. 53:4845-4851
CS-8958 is a prodrug of the pharmacologically active form R-125489, a selective neuraminidase inhibitor, and has long-acting anti-influenza virus activity in vivo. In this study, the tissue distribution profiles after a single intranasal administrati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::178e84fc2197dad82ec25ea5b17a1850
https://doi.org/10.1128/aac.00731-09
https://doi.org/10.1128/aac.00731-09